Beneficial Effects of Mindfulness-based Training on Neuropsychological Outcomes in Mild Cognitive Impairment (MEDIC)
Mild Cognitive Impairment

About this trial
This is an interventional treatment trial for Mild Cognitive Impairment focused on measuring Mindfulness, Cognitive Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Fluent in English
- Mild Cognitive Impairment: Fulfill Diagnostic and Statistical Manual of Mental Disorders version five (DSM-V) diagnostic criteria for Minor Neurocognitive Disorder
- MMSE score = 20-30
- Clinical Dementia Rating Score (CDR) = 0.5
- Age: ≤75 years
Exclusion Criteria:
- Presence of major neurological conditions such as epilepsy, stroke, Parkinson's Disease and or brain injury
- Presence of major psychiatric conditions such as major depression or schizophrenia
- Unsuitability for fMRI scanning (e.g. pacemakers, metallic implants, claustrophobia)
- Unable to give or no consent available
- Left-handed participants may take part in the study but will not undergo fMRI scanning
Sites / Locations
- Singapore General Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Mindfulness-Based Intervention
Cognitive Rehabilitation Training
Treatment As Usual
Participants in this arm will complete baseline and follow-up visits (approximately 3-months after) and Mid-intervention safety checks. They will attend the in the Mindfulness-Based Training program that will meet weekly for 8 weeks. Each session will last approximately one-and-a-half hours.
Participants in this arm will complete baseline and follow-up visits (approximately 3-months after) and Mid-intervention safety checks. They will attend the Cognitive Rehabilitation program that will meet weekly for 8 weeks. Each session will last one-and-a-half hours.
Participants in the Treatment As Usual group were only required to attend baseline and follow-up visits (approximately 3-months after) and Mid-intervention safety checks. Participants in this group will not receive an intervention for the duration of the study. They received treatment as usual which is 6 months to 1-year follow up visits with their attending neurologist of psychologist.